In both acute and chronic colitis models, vehicle-treated mice showed a significant increase in pro-inflammatory cytokines, IL-6, IL-1β, MCP-1, and TNF-α, compared to healthy controls, which was markedly attenuated by the combination therapies (Figure 5 and Figure 6). This evidence concerns the gene IL1B and colitis.